Stock listing
Frankfurt:TEN Tecan Group AG Aktie
German listing (Frankfurt) of Tecan Group AG · home listing SIX Swiss:TECN
Follow Tecan Group AG into a list and get an email when it puts out news.
Home listing price · SIX:TECN
238.60 CHF +1.60 (+0.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:TECN
- Day range
- 235.20 – 241.80 CHFNov 20, 2026
- Volume
- 56,605 sharesNov 20, 2026
- Market cap
- 2.94B CHFAt the close on Nov 20, 2026 · price × 12.32M shares outstanding
- 52-week range
- 110.60 – 276.20 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 15.75M CHFMedian day 60,797 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:TECN · Home | 238.60 CHF | +1.60 (+0.7%) | 56,605 | 241.00 | 241.80 | 235.20 | 237.00 | Close on Nov 20, 2026 |
| LSE:0QLN | 236.60 CHF | -5.50 (-2.3%) | 6,357 | 240.10 | 240.60 | 235.70 | 242.10 | Close on Nov 20, 2026 |
| OTC:TCGGY | $64.10 USD | -1.21 (-1.9%) | 2 | $64.10 | $64.10 | $64.10 | $65.31 | Close on Nov 10, 2026 |
| Munich:TEN | €259.20 EUR | +1.00 (+0.4%) | — | €260.00 | €260.00 | €259.20 | €258.20 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:TECN · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 238.60 | +1.60 | +0.7% | 241.00 | 241.80 | 235.20 | 56,605 | |
| 237.00 | +4.00 | +1.7% | 235.60 | 242.00 | 233.40 | 49,627 | |
| 233.00 | -15.80 | -6.4% | 247.00 | 248.20 | 230.00 | 107,359 | |
| 248.80 | -2.40 | -1.0% | 248.00 | 254.00 | 248.00 | 34,605 | |
| 251.20 | -4.40 | -1.7% | 254.60 | 256.20 | 251.20 | 43,664 | |
| 255.60 | -4.80 | -1.8% | 260.00 | 260.60 | 250.00 | 57,078 | |
| 260.40 | +2.00 | +0.8% | 259.20 | 261.80 | 255.00 | 34,264 | |
| 258.40 | +0.20 | +0.1% | 260.20 | 263.00 | 257.60 | 38,748 | |
| 258.20 | +0.60 | +0.2% | 261.60 | 262.00 | 254.60 | 38,548 | |
| 257.60 | -4.40 | -1.7% | 254.00 | 260.20 | 250.00 | 75,590 | |
| 262.00 | +17.40 | +7.1% | 259.00 | 276.20 | 256.40 | 176,921 | |
| 244.60 | -2.20 | -0.9% | 245.80 | 248.20 | 242.00 | 69,962 | |
| 246.80 | +1.00 | +0.4% | 243.20 | 249.20 | 237.80 | 85,617 | |
| 245.80 | -1.20 | -0.5% | 246.20 | 250.00 | 241.60 | 67,627 | |
| 247.00 | -8.20 | -3.2% | 251.80 | 254.00 | 244.80 | 92,268 | |
| 255.20 | +8.40 | +3.4% | 247.60 | 255.20 | 245.40 | 159,147 | |
| 246.80 | +3.80 | +1.6% | 240.00 | 251.40 | 239.80 | 51,099 | |
| 243.00 | +0.40 | +0.2% | 243.20 | 244.40 | 240.20 | 61,177 | |
| 242.60 | -2.80 | -1.1% | 245.40 | 248.40 | 242.60 | 34,769 | |
| 245.40 | -5.80 | -2.3% | 250.80 | 250.80 | 243.80 | 33,396 | |
| 251.20 | +5.40 | +2.2% | 244.60 | 253.40 | 244.20 | 49,594 | |
| 245.80 | +1.80 | +0.7% | 246.20 | 249.60 | 243.00 | 60,748 | |
| 244.00 | +8.60 | +3.7% | 235.60 | 249.20 | 234.00 | 68,242 | |
| 235.40 | -5.80 | -2.4% | 239.60 | 241.60 | 234.20 | 78,275 | |
| 241.20 | -6.40 | -2.6% | 245.80 | 249.80 | 241.20 | 69,403 | |
| 247.60 | +0.60 | +0.2% | 249.00 | 252.00 | 244.00 | 76,983 | |
| 247.00 | +7.60 | +3.2% | 239.80 | 247.60 | 239.40 | 67,988 | |
| 239.40 | +2.40 | +1.0% | 237.00 | 239.40 | 235.00 | 57,930 | |
| 237.00 | +2.00 | +0.9% | 236.00 | 240.00 | 235.00 | 61,557 | |
| 235.00 | +5.60 | +2.4% | 231.40 | 236.60 | 228.20 | 68,375 | |
| 229.40 | -9.80 | -4.1% | 236.20 | 239.20 | 226.80 | 146,724 | |
| 239.20 | -8.20 | -3.3% | 242.60 | 245.60 | 234.60 | 99,459 | |
| 247.40 | +3.80 | +1.6% | 244.00 | 256.80 | 244.00 | 180,483 | |
| 243.60 | +12.40 | +5.4% | 236.40 | 248.60 | 234.80 | 123,752 | |
| 231.20 | +0.20 | +0.1% | 230.00 | 233.00 | 227.60 | 62,612 | |
| 231.00 | -3.40 | -1.5% | 234.00 | 234.80 | 230.00 | 73,664 | |
| 234.40 | +1.40 | +0.6% | 233.00 | 235.60 | 231.00 | 137,374 | |
| 233.00 | +2.80 | +1.2% | 231.00 | 237.20 | 230.40 | 92,000 | |
| 230.20 | +7.00 | +3.1% | 227.60 | 233.60 | 225.80 | 58,780 | |
| 223.20 | -4.80 | -2.1% | 228.00 | 229.60 | 222.40 | 92,509 | |
| 228.00 | +10.20 | +4.7% | 217.00 | 228.60 | 217.00 | 100,500 | |
| 217.80 | -0.60 | -0.3% | 218.20 | 219.80 | 216.80 | 38,778 | |
| 218.40 | +6.80 | +3.2% | 214.20 | 219.40 | 211.80 | 37,465 | |
| 211.60 | -7.20 | -3.3% | 218.60 | 219.80 | 211.60 | 84,719 | |
| 218.80 | 0.00 | 0.0% | 220.00 | 222.00 | 218.20 | 99,808 | |
| 218.80 | +3.80 | +1.8% | 214.80 | 218.80 | 212.20 | 65,319 | |
| 215.00 | +4.60 | +2.2% | 210.00 | 215.00 | 208.60 | 116,131 | |
| 210.40 | +13.40 | +6.8% | 197.00 | 210.40 | 196.80 | 73,507 | |
| 197.00 | -2.00 | -1.0% | 198.80 | 201.80 | 197.00 | 29,312 | |
| 199.00 | +3.20 | +1.6% | 197.80 | 200.00 | 195.50 | 49,133 | |
| 195.80 | -1.20 | -0.6% | 198.90 | 200.00 | 193.90 | 32,808 | |
| 197.00 | -0.80 | -0.4% | 196.80 | 198.80 | 194.70 | 25,679 | |
| 197.80 | +0.80 | +0.4% | 198.00 | 200.00 | 196.20 | 53,158 | |
| 197.00 | +2.10 | +1.1% | 192.60 | 197.00 | 191.90 | 23,271 | |
| 194.90 | -0.70 | -0.4% | 195.00 | 196.70 | 194.00 | 46,114 | |
| 195.60 | -0.40 | -0.2% | 195.70 | 199.70 | 195.30 | 58,123 | |
| 196.00 | +0.20 | +0.1% | 195.60 | 200.20 | 193.40 | 54,787 | |
| 195.80 | -1.80 | -0.9% | 196.00 | 201.00 | 193.90 | 60,845 | |
| 197.60 | +3.20 | +1.6% | 194.40 | 197.60 | 193.00 | 88,556 | |
| 194.40 | +3.00 | +1.6% | 190.30 | 196.40 | 188.70 | 44,402 | |
| 191.40 | +3.30 | +1.8% | 188.10 | 191.50 | 186.20 | 39,510 | |
| 188.10 | -5.20 | -2.7% | 185.00 | 189.60 | 183.00 | 48,500 | |
| 193.30 | +0.60 | +0.3% | 193.10 | 195.00 | 191.20 | 19,494 | |
| 192.70 | +1.60 | +0.8% | 189.80 | 194.10 | 189.80 | 24,726 | |
| 191.10 | -5.90 | -3.0% | 197.40 | 197.40 | 191.10 | 35,039 | |
| 197.00 | +5.80 | +3.0% | 192.10 | 197.00 | 192.10 | 49,813 |
Splits
2 splits since 1999 · SIX:TECN · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 10-for-1 | Split | |
| 10-for-1 | Split |
- Ticker
- Frankfurt:TEN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Sep 10, 2026
Tecan to participate in upcoming Investor Conference
Latest earnings call · Aug 11, 2026
Tecan Group (SIX Swiss: TECN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 11, 2026
H1 2026 Earnings Presentation
Earnings · 22 slides
Latest news
Tecan to participate in upcoming Investor Conference
Sep 10, 2026
Closed 195.80 (-0.6%) on Sep 10, 2026
Tecan reports growth of 3.4% in local currencies and adjusted EBITDA margin of 15.1% for the first half of 2026, outlook confirmed
Aug 11, 2026
Closed 181.20 (-10.3%) on Aug 11, 2026
Tecan schedules conference call on August 11th to discuss half year 2026 financial results
Aug 4, 2026
Closed 193.80 (+0.5%) on Aug 4, 2026
Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA
Jun 24, 2026
Closed 155.70 (+3.8%) on Jun 24, 2026
Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India
May 26, 2026
Closed 149.10 (-0.2%) on May 26, 2026
Q1 2026 Update: Tecan on track with low-single-digit local currency growth in Q1; full-year 2026 outlook confirmed
May 12, 2026
Closed 135.20 (+2.8%) on May 12, 2026
Annual General Meeting 2026: Tecan shareholders endorse all motions proposed by the Board of Director including stable dividend of CHF 3.00 per share
Apr 15, 2026
Closed 139.80 (-1.1%) on Apr 16, 2026
Camila Japur joins Tecan as Chief Financial Officer
Mar 30, 2026
Closed 129.20 (+1.7%) on Mar 30, 2026
Annual General Meeting 2026: Tecan proposes the election of three new members of the Board of Directors and a new Chairman
Mar 25, 2026
Closed 126.60 (+1.2%) on Mar 25, 2026
Tecan to create Data-Driven Labs with NVIDIA
Mar 17, 2026
Closed 121.60 (+3.6%) on Mar 17, 2026
Tecan Group AG on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 16 in the last 12 months · 30 in all · newest Sep 10, 2026 · oldest 2025
- Calls
- 5 calls with a replay · 5 with a transcript · latest Aug 11, 2026
- Decks
- 53 decks · latest Aug 11, 2026
Where Tecan Group AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:TECN · Home listing | SIX Swiss | Switzerland | CHF |
| OTC:TCHBF | OTC | United States | USD |
| LSE:0QLN | LSE | United Kingdom | CHF |
| gettex:TEN | gettex | Germany | EUR |
| Milan:1TECN | Milan | Italy | EUR |
| LS Exchange:922557 | LS Exchange | Germany | EUR |
| Lang & Schwarz:922557 | Lang & Schwarz | Germany | EUR |
| Frankfurt:TEN · This page | Frankfurt | Germany | EUR |
| OTC:TCGGY | OTC | United States | USD |
| Aquis:TECNZ | Aquis | United Kingdom | CHF |
| VIE:TECN | Vienna | Austria | EUR |
| BX Swiss:TEN | BX Swiss | Switzerland | CHF |
| Munich:TEN | Munich | Germany | EUR |
| Stuttgart:TEN | Stuttgart | Germany | EUR |
| Tradegate:TEN | Tradegate | Germany | EUR |
| Turquoise:TECNZ | Turquoise | United Kingdom | CHF |
| Dusseldorf:TEN | Dusseldorf | Germany | EUR |
| Hamburg:TEN | Hamburg | Germany | EUR |
Valuation
EV/sales 3.3× against a median of 6.2×: 3rd lowest of 11 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 2.93B CHF
- P/E
- Loss
- EV/sales
- 3.3×
- EV/EBITDA
- 34.0×
- Price/book
- 2.6×
- Gross margin
- 31.8%
- Operating margin
- 2.9%
- Net margin
- −12.5%
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Tecan Group AG · SIX:TECN | US$3.50B | US$3.49B | n/a | 3.3× | 34.0× | 2.6× | −12.5% | 0.2× | n/a |
| SAI Life Sciences Ltd. · NSE:SAILIFE | US$4.13B | US$4.13B | 106× | 17.0× | 58.1× | 15.4× | 16.1% | 0.0× | n/a |
| BillionToOne, Inc. · NASDAQ:BLLN | US$3.83B | US$3.36B | 77.6× | 7.7× | 59.6× | 6.8× | 11.3% | 0.2× | 1.35 |
| CareDx, Inc. · NASDAQ:CDNA | US$3.68B | US$3.43B | 28.6× | 6.9× | n/a | 7.9× | 25.9% | 0.0× | 1.26 |
| Piramal Pharma Limited · NSE:PPLPHARMA | US$3.42B | US$3.97B | n/a | 3.8× | 30.6× | 3.9× | −2.1% | 0.7× | n/a |
| Siegfried Holding AG · SIX:SFZN | US$3.40B | US$4.38B | 16.9× | 2.8× | 12.0× | 2.9× | 12.7% | 0.9× | n/a |
| Apeloa Pharmaceutical Co. Ltd. Class A · SZSE:000739 | US$3.29B | US$2.84B | 27.3× | 2.1× | n/a | 3.4× | 9.1% | 0.1× | n/a |
| Autobio Diagnostics Co., Ltd. Class A · SSE:603658 | US$3.28B | US$3.05B | 20.8× | 4.7× | n/a | 2.4× | 24.3% | 0.0× | n/a |
| Joinn Laboratories (China) Co., Ltd. Class A · SSE:603127 | US$3.04B | US$2.66B | 17.7× | 9.6× | n/a | 2.2× | 61.6% | 0.0× | n/a |
| MGI Tech Co., Ltd. Class A · SSE:688114 | US$2.92B | US$2.53B | n/a | 5.5× | n/a | 2.8× | −9.5% | 0.2× | n/a |
| Neuland Laboratories Ltd. · NSE:NEULANDLAB | US$2.86B | US$2.80B | 58.5× | 11.3× | 36.8× | 13.1× | 19.6% | 0.2× | n/a |
| Median of the others | US$3.34B | US$3.21B | 27.9× | 6.2× | 36.8× | 3.7× | 14.4% | 0.1× | 1.31 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 222.72 CHF · Analysts' mean
- EPS, year to Dec 2026
- 6.83 · 7 analysts
- Revenue, year to Dec 2026
- 897.9M · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Camila Japur | Chief Financial Officer |
| Martin Braendle | Senior Vice President, Corporate Communications & IR |
| Martin Brändle | Senior Vice President, Corporate Communications & IR |
Board
| Director | Role |
|---|---|
| Christa Kreuzburg | Member of the Compensation Committee |
| Daniel R. Marshak | Member of the Compensation Committee |
| Gitte Pugholm Aabo | Member of the Audit Committee |
| Guillaume Daniellot | Chair of the Audit Committee |
| Myra Eskes | Vice Chair of the Board |
| Nina Beikert | Member of the Nomination and Governance Committee |
Events
- Next results
- Mar 10, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Tecan Group (SIX Swiss: TECN) Q2 2026 Earnings Call | Tue, Aug 11, 2026 · 1:00 AM ET | Replay |
| Tecan Group (SIX Swiss: TECN) Q4 2025 Earnings Call | Tue, Aug 12, 2025 · 2:30 AM ET | Replay |
| Tecan Group (SIX Swiss: TECN) Q4 2024 Earnings Call | Wed, Mar 12, 2025 · 2:30 AM ET | Replay |
| Tecan Group (SIX Swiss: TECN) Q2 2024 Earnings Call | Tue, Aug 13, 2024 · 2:30 AM ET | Replay |
| Tecan Group (SIX Swiss: TECN) Q4 2023 Earnings Call | Tue, Mar 12, 2024 · 7:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Mar 16, 2026 · After close | +3.6% |
| Q2 2025 | Aug 12, 2025 · After close | −0.3% |
| Q4 2024 | Mar 12, 2025 | −6.9% |
| Quarter to Sep 30, 2024 | Nov 18, 2024 | −0.7% |
| Q2 2024 | Aug 8, 2024 | +0.7% |
| Quarter to Mar 31, 2024 | Jun 12, 2024 · After close | −0.3% |
| Q4 2023 | Mar 12, 2024 | −0.5% |
| Quarter to Sep 30, 2023 | Nov 1, 2023 | +3.9% |
| Q2 2023 | Aug 15, 2023 · Before open | +7.8% |
| Quarter to Mar 31, 2023 | May 4, 2023 | +0.1% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Mar 14, 2023 · Before open | +3.8% |
| Q3 2022 | Nov 2, 2022 | −1.8% |
| Q2 2022 | Aug 17, 2022 · Before open | +8.3% |
| Q1 2022 | May 5, 2022 | +0.1% |
| Q4 2021 | Mar 15, 2022 · Before open | −16.0% |
| Q3 2021 | Nov 3, 2021 | +1.7% |
| Q2 2021 | Aug 18, 2021 | +4.4% |
| Q1 2021 | May 6, 2021 | −0.8% |
| Q4 2020 | Mar 16, 2021 | +1.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 22 slides | Aug 11, 2026 |
| H1 2025 Earnings Presentation | Earnings | 25 slides | Aug 12, 2025 |
| Mimetas — Technical Presentation (2023) | Technical | 20 slides | Apr 24, 2023 |
| Technical Presentation (2023) | Technical | 28 slides | Apr 24, 2023 |
| SLAS 2023 | Conference | 29 slides | Feb 27, 2023 |
| H1 2021 Earnings Presentation | Earnings | 26 slides | Aug 18, 2021 |
| FY2020 Earnings Presentation | Earnings | 29 slides | Mar 16, 2021 |
| Annual J.P. Morgan Healthcare Conference 2021 | Conference | 17 slides | Jan 14, 2021 |
| H1 2020 Earnings Presentation | Earnings | 30 slides | Aug 12, 2020 |
| UBS Virtual Global Healthcare Conference 2020 | Conference | 23 slides | May 18, 2020 |
Show 50 decks
This page holds 50 of 53 decks. Open Decks
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Fixed rate domestic straight bond Announced: CHF 150M · UBS Investment Bank +2 Dealers: UBS Investment Bank (lead), Zürcher Kantonalbank (lead), Bank J. Safra Sarasin (co-lead) Use of proceeds: General corporate purposes, including repaying the outstanding CHF 250 million bond maturing in October 2025 | Aug 14, 2025 | US$185.69M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CHF
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 882.5M | 934.3M | 1.07B | 1.14B | 946.6M | 730.9M | 636.8M | 593.8M | 548.6M | 506.2M |
| Cost of revenue | 602.3M | 613.7M | 683.9M | 738.9M | 558.6M | 391.0M | 354.1M | 315.8M | 283.8M | 266.9M |
| Gross profit | 280.2M | 320.6M | 390.5M | 405.3M | 388.0M | 339.9M | 282.7M | 278.0M | 264.8M | 239.4M |
| Research and development | 68.6M | 68.4M | 70.0M | 61.0M | 59.8M | 48.6M | 48.9M | 63.7M | 62.3M | 55.0M |
| Selling, general and administrative | 86.9M | 73.2M | 72.0M | 81.4M | 75.5M | 66.0M | 56.6M | 51.4M | 51.3M | 48.1M |
| Operating income | 25.2M | 75.6M | 136.0M | 146.0M | 141.1M | 123.0M | 88.9M | 87.4M | 81.8M | 68.7M |
| Depreciation and amortization | 61.0M | 66.8M | 70.8M | 67.1M | 59.0M | 37.7M | 34.1M | 21.8M | 24.8M | 20.9M |
| EBITDA | 86.2M | 142.4M | 206.8M | 213.0M | 200.2M | 160.7M | 123.0M | 109.2M | 106.6M | 89.5M |
| Interest expense | 3.32M | 2.71M | 1.33M | 1.48M | 4.25M | 1.32M | 1.12M | 477.0K | 471.0K | 345.0K |
| Income before tax | -101.3M | 78.3M | 133.8M | 142.5M | 137.9M | 118.2M | 82.7M | 83.4M | 79.0M | 65.4M |
| Income tax | 9.40M | 10.6M | 1.73M | 21.4M | 16.3M | 14.5M | 9.57M | 12.7M | 13.1M | 10.9M |
| Net income | -110.7M | 67.7M | 132.1M | 121.1M | 121.7M | 103.7M | 73.2M | 70.7M | 66.5M | 54.5M |
| Earnings per share, basic | -8.74 | 5.29 | 10.30 | 9.47 | 9.88 | 8.62 | 6.13 | 5.96 | 5.64 | 4.66 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 176.4M | 154.2M | 133.0M | 111.4M | 121.0M | 148.4M | 266.3M | 296.8M | 309.4M | 246.7M |
| Short-term investments | 135.0M | 251.8M | 233.5M | 181.8M | 120.9M | 322.5M | 50.5M | 977.0K | 1.02M | 3.04M |
| Receivables | 165.6M | 195.8M | 194.2M | 196.1M | 168.6M | 138.3M | 137.2M | 122.6M | 112.7M | 97.0M |
| Inventory | 212.6M | 230.5M | 254.4M | 300.6M | 249.1M | 159.5M | 151.9M | 171.7M | 160.2M | 168.4M |
| Current assets | 711.7M | 856.3M | 850.6M | 803.5M | 671.9M | 778.0M | 615.5M | 596.0M | 602.2M | 534.3M |
| Property, plant and equipment | 132.8M | 147.3M | 145.2M | 149.4M | 150.3M | 79.2M | 72.8M | 25.1M | 21.3M | 20.3M |
| Goodwill | 553.1M | 761.0M | 710.0M | 775.1M | 767.1M | 136.1M | 142.7M | 133.5M | 101.6M | 98.2M |
| Total assets | 1.70B | 2.12B | 2.07B | 2.16B | 2.04B | 1.13B | 939.8M | 857.7M | 804.0M | 736.2M |
| Accounts payable | 27.8M | 33.6M | 39.2M | 34.3M | 27.6M | 11.9M | 10.4M | 14.4M | 13.9M | 10.1M |
| Current liabilities | 288.8M | 531.3M | 296.9M | 336.3M | 306.4M | 225.0M | 157.3M | 163.5M | 153.1M | 142.0M |
| Long-term debt | 150.3M | 0 | 249.8M | 249.6M | 250.2M | 734.0K | 339.0K | 1.18M | 8.00M | 9.98M |
| Total debt | 218.3M | 321.3M | 316.1M | 307.7M | 313.7M | 38.7M | 47.9M | 7.23M | 17.2M | 12.0M |
| Total liabilities | 546.6M | 686.2M | 725.1M | 776.4M | 800.3M | 380.5M | 280.7M | 245.3M | 253.8M | 249.1M |
| Shareholders' equity | 1.15B | 1.44B | 1.35B | 1.36B | 1.22B | 733.7M | 659.1M | 612.4M | 550.1M | 487.1M |
| Shares outstanding | 12.7M | 12.8M | 12.8M | 12.8M | 12.3M | 12.0M | 11.9M | 11.9M | 11.8M | 11.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 138.0M | 148.5M | 160.6M | 128.3M | 169.9M | 208.3M | 98.8M | 92.7M | 99.4M | 118.8M |
| Capital spending | -35.3M | -30.7M | -34.9M | -36.2M | -39.7M | -41.3M | -23.9M | -11.8M | -8.14M | -6.78M |
| Free cash flow | 102.7M | 117.9M | 125.6M | 92.0M | 130.1M | 167.0M | 74.9M | 80.9M | 91.3M | 112.0M |
| Cash from investing | 76.5M | -48.6M | -84.2M | -88.2M | -651.9M | -288.7M | -99.1M | -78.4M | -22.4M | -54.3M |
| Cash from financing | -187.5M | -81.3M | -50.6M | -48.6M | 454.5M | -36.3M | -29.4M | -26.2M | -15.2M | -26.2M |
| Dividends paid | -38.0M | -38.3M | -37.0M | -35.6M | -27.6M | -26.2M | -24.8M | -23.5M | -20.3M | -20.1M |
| Share buybacks | -33.4M | -28.9M | 0 | -1.00K | 357.5M | -460.0K | -1.67M | -917.0K | -1.79M | 7.07M |
| Change in cash | 22.2M | 21.2M | 21.5M | -9.56M | -27.4M | -117.8M | -30.6M | -12.6M | 62.7M | 38.3M |
Cap table
Built by 6ix from Tecan Group AG’s releases · as of Aug 14, 2025
- Common shares
- 12,321,807
- Fully diluted
- 12,321,807
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 12,321,807 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 12,321,807 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Camila Japur | Chief Financial Officer · Since at least Mar 30, 2026 |
| Christa Kreuzburg | Member of the Compensation Committee · Since at least Apr 15, 2026 |
| Daniel R. Marshak | Member of the Compensation Committee · Since at least Apr 15, 2026 |
| Gitte Pugholm Aabo | Member of the Audit Committee · Since at least Apr 15, 2026 |
| Guillaume Daniellot | Chair of the Audit Committee · Since at least Apr 15, 2026 |
| Martin Braendle | Senior Vice President, Corporate Communications & IR · Since at least Aug 4, 2026 |
| Martin Brändle | Senior Vice President, Corporate Communications & IR · Since at least Sep 10, 2026 |
| Matthias Gillner | Chair of the Board · Until Mar 25, 2026 · Past |
| Myra Eskes | Vice Chair of the Board · Since at least Apr 15, 2026 |
| Nina Beikert | Member of the Nomination and Governance Committee · Since at least Apr 15, 2026 |
Log in to ask 6ix AI your own questions about Tecan Group AG.